As a manufacturer of COVID-19 tests – and the top provider of COVID-19 testing in California – the company featured in today’s article has seen its shares skyrocket over 970% over the past year. But with the U.S. on track to vaccinate every American adult who wants to be vaccinated by the end of July, is the company’s spectacular growth story nearing its end, or could its core business – and continued transmission of COVID-19 even with a vaccinated population – help it continue to deliver multibagger returns? CLICK HERE.
Is This COVID-19 Test Manufacturer’s Spectacular Growth Story Nearing Its End – Or Entering The Next Chapter?
- by RobH
Tags:COVID-19COVID-19 Vaccine StocksInvestmentinvestorsMultibagger ReturnsSharesStock MarketstocksU.S. Vaccination